Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-01-12 | 2023-02-16 | 180903 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183367 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2021-09-02 | 2021-09-09 | 145109 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2021-03-18 | 2021-04-08 | 135961 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Resolved | 2019-11-07 | 2020-01-30 | 98182 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2020-02-07 | 2020-03-05 | 105573 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Resolved | 2019-06-27 | 2019-08-16 | 87705 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2017-08-01 | 2017-09-19 | 17881 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2017-08-01 | 2017-09-19 | 17884 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2024-03-28 | 2024-04-11 | 223835 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Resolved | 2024-04-18 | 2024-06-20 | 225483 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2025-01-30 | 2025-03-20 | 249192 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Actual shortage | 2025-04-04 | 2025-04-24 | 254133 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2020-03-26 | 2020-05-08 | 109618 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Resolved | 2020-04-23 | 2020-06-04 | 113022 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-09-02 | 2021-12-02 | 145106 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-09-30 | 2021-10-21 | 146437 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-01-13 | 2022-02-17 | 152685 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-02-17 | 2023-02-09 | 155140 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-04-21 | 2022-10-29 | 159186 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |